# Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

> **NCT00984529** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 500 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00984529
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2011-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984529, "Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00984529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*